These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 1400978)
1. Optimum use of selective plated media in primary processing of respiratory tract specimens from patients with cystic fibrosis. Doern GV; Brogden-Torres B J Clin Microbiol; 1992 Oct; 30(10):2740-2. PubMed ID: 1400978 [TBL] [Abstract][Full Text] [Related]
2. Cefsulodin chocolate blood agar: a selective medium for the recovery of Haemophilus influenzae from the respiratory secretions of patients with cystic fibrosis. Smith A; Baker M J Med Microbiol; 1997 Oct; 46(10):883-5. PubMed ID: 9364146 [TBL] [Abstract][Full Text] [Related]
3. Isolation medium for the recovery of Pseudomonas cepacia from respiratory secretions of patients with cystic fibrosis. Gilligan PH; Gage PA; Bradshaw LM; Schidlow DV; DeCicco BT J Clin Microbiol; 1985 Jul; 22(1):5-8. PubMed ID: 4019742 [TBL] [Abstract][Full Text] [Related]
4. Selective and differential medium for recovery of Pseudomonas cepacia from the respiratory tracts of patients with cystic fibrosis. Welch DF; Muszynski MJ; Pai CH; Marcon MJ; Hribar MM; Gilligan PH; Matsen JM; Ahlin PA; Hilman BC; Chartrand SA J Clin Microbiol; 1987 Sep; 25(9):1730-4. PubMed ID: 3654943 [TBL] [Abstract][Full Text] [Related]
5. Compliance of clinical microbiology laboratories in the United States with current recommendations for processing respiratory tract specimens from patients with cystic fibrosis. Zhou J; Garber E; Desai M; Saiman L J Clin Microbiol; 2006 Apr; 44(4):1547-9. PubMed ID: 16597890 [TBL] [Abstract][Full Text] [Related]
6. Comparison of isolation media for recovery of Burkholderia cepacia complex from respiratory secretions of patients with cystic fibrosis. Henry D; Campbell M; McGimpsey C; Clarke A; Louden L; Burns JL; Roe MH; Vandamme P; Speert D J Clin Microbiol; 1999 Apr; 37(4):1004-7. PubMed ID: 10074517 [TBL] [Abstract][Full Text] [Related]
7. [Isolation frequency of Burkholderia cepacia from cystic fibrosis patients]. Ocak F; Gözalan A; Ozçelik U; Anadol D; Kiper N; Aktepe OC; Göçmen A; Esen B Mikrobiyol Bul; 2002 Jan; 36(1):1-10. PubMed ID: 12476760 [TBL] [Abstract][Full Text] [Related]
8. Identification of Burkholderia cepacia isolates from patients with cystic fibrosis and use of a simple new selective medium. Henry DA; Campbell ME; LiPuma JJ; Speert DP J Clin Microbiol; 1997 Mar; 35(3):614-9. PubMed ID: 9041399 [TBL] [Abstract][Full Text] [Related]
9. Practical Guidance for Clinical Microbiology Laboratories: Updated guidance for processing respiratory tract samples from people with cystic fibrosis. Saiman L; Waters V; LiPuma JJ; Hoffman LR; Alby K; Zhang SX; Yau YC; Downey DG; Sermet-Gaudelus I; Bouchara J-P; Kidd TJ; Bell SC; Brown AW Clin Microbiol Rev; 2024 Sep; 37(3):e0021521. PubMed ID: 39158301 [TBL] [Abstract][Full Text] [Related]
10. Detection of hyphomycetes in the upper respiratory tract of patients with cystic fibrosis. Horré R; Marklein G; Siekmeier R; Reiffert SM Mycoses; 2011 Nov; 54(6):514-22. PubMed ID: 20492536 [TBL] [Abstract][Full Text] [Related]
11. Primary culture media for routine urine processing. Fung JC; Lucia B; Clark E; Berman M; Goldstein J; D'Amato RF J Clin Microbiol; 1982 Oct; 16(4):632-6. PubMed ID: 7153312 [TBL] [Abstract][Full Text] [Related]
12. Comparative evaluation of selective media for isolation of Pseudomonas cepacia from cystic fibrosis patients and environmental sources. Carson LA; Tablan OC; Cusick LB; Jarvis WR; Favero MS; Bland LA J Clin Microbiol; 1988 Oct; 26(10):2096-100. PubMed ID: 3182996 [TBL] [Abstract][Full Text] [Related]
13. Selective media for the quantitation of bacteria in cystic fibrosis sputum. Wong K; Roberts MC; Owens L; Fife M; Smith AL J Med Microbiol; 1984 Apr; 17(2):113-9. PubMed ID: 6423825 [TBL] [Abstract][Full Text] [Related]
14. Use of selective media in bacteriological investigation of patients with chronic suppurative respiratory infection. Roberts DE; Cole P Lancet; 1980 Apr; 1(8172):796-7. PubMed ID: 6102681 [No Abstract] [Full Text] [Related]
15. In vitro activity of tosufloxacin, a new quinolone, against respiratory pathogens derived from cystic fibrosis sputum. Arguedas AG; Akaniro JC; Stutman HR; Marks MI Antimicrob Agents Chemother; 1990 Nov; 34(11):2223-7. PubMed ID: 2073112 [TBL] [Abstract][Full Text] [Related]
16. Development of selective media for the isolation of yeasts and filamentous fungi from the sputum of adult patients with cystic fibrosis (CF). Nagano Y; Millar BC; Goldsmith CE; Walker JM; Elborn JS; Rendall J; Moore JE J Cyst Fibros; 2008 Nov; 7(6):566-72. PubMed ID: 18723404 [TBL] [Abstract][Full Text] [Related]
17. Selective media for recovery of Haemophilus influenzae from specimens contaminated with upper respiratory tract microbial flora. Chapin KC; Doern GV J Clin Microbiol; 1983 Jun; 17(6):1163-5. PubMed ID: 6603468 [TBL] [Abstract][Full Text] [Related]
18. Utility of gram stain in evaluation of sputa from patients with cystic fibrosis. Sadeghi E; Matlow A; MacLusky I; Karmali MA J Clin Microbiol; 1994 Jan; 32(1):54-8. PubMed ID: 7510312 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of Pseudomonas aeruginosa from cystic fibrosis by selective media. Fonseca K; MacDougall J; Pitt TL J Clin Pathol; 1986 Feb; 39(2):220-2. PubMed ID: 3081597 [TBL] [Abstract][Full Text] [Related]
20. Laboratory proficiency test results on use of selective media for isolating Pseudomonas cepacia from simulated sputum specimens of patients with cystic fibrosis. Tablan OC; Carson LA; Cusick LB; Bland LA; Martone WJ; Jarvis WR J Clin Microbiol; 1987 Mar; 25(3):485-7. PubMed ID: 3571451 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]